Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study
Titel:
Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study
Auteur:
Tabernero, Josep Hoff, Paulo M Shen, Lin Ohtsu, Atsushi Shah, Manish A Cheng, Karen Song, Chunyan Wu, Haiyan Eng-Wong, Jennifer Kim, Katherine Kang, Yoon-Koo